Protein arginine methyltransferase 5 regulates SHH-subgroup medulloblastoma progression is a research paper published in Neuro-Oncology Advances (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01NS110591
National Institutes of Health
Grant: R50CA221838
National Cancer Institute
Grant: T32 CA009686
Live Like Bella Pediatric Cancer Research Initiative
Grant: 8LA03 to D.J.R.
Hollings Cancer Center
Grant: IRG-19-137-20
Rally Foundation Career Development
Grant: 20CDN46
National Institute of Neurological Disorders and Stroke
Grant: K01NS119351
SCTR
Grant: UL1TR001450
National Institutes of Health
Grant: 5R01NS110591-04
Novel regulators of Gli-driven medulloblastoma
National Institutes of Health
Grant: 3UL1TR001450-06S1
South Carolina Clinical & Translational Research Institute (SCTR)
National Institutes of Health
Grant: 2R50CA221838-06
Advancing Cancer Research through Comprehensive Proteomics and Metabolomics Analyses
National Institutes of Health
Grant: 3T32CA009686-05S1
TRAINING GRANT IN TUMOR BIOLOGY
National Institutes of Health
Grant: 5K01NS119351-03
Identifying Novel Therapeutics for High Risk Medulloblastoma Patients
American Cancer Society Institutional Research
FWCI
0.24
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals